Massachusetts Eye and Ear and Massachusetts General Hospital, both in Boston, are working together to develop a COVID-19 vaccine and hope to begin testing in healthy volunteers by the end of the year.
The hospitals’ vaccine would use a harmless virus called an adeno-associated virus to deliver DNA into the body that would stimulate the immune system to make antibodies to attack the coronavirus if a person is exposed to it, according to The Boston Globe.
Mr. Grousbeck donated $1 million to the hospitals to support their vaccine development efforts.
“We will need several vaccines to succeed to cure the world, and we’re trying to cure the world here,” Mr. Grousbeck told The Boston Globe.
Read the full article here.
More articles on pharmacy:
6 federal pharmacy policy changes in response to the COVID-19 pandemic
Clinical trials for COVID-19 drugs & when to expect results
Walgreens lowers prices on hundreds of prescription drugs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
